Kathryn Brown writes about Gilead Sciences and its founder and CEO / Chairman Michael L. Riordan. Topics include antiviral medicines; research and development of drugs against AIDS / HIV, influenza & hepatitis; viruses; the founding of Gilead; dengue fever; biotechnology; neuraminidase; drug discovery; Washington University, Luce Scholarship. Published in Washington University Magazine, 1997.